SRBT | Shanrong Biotechnology Corp. Annual & Quarterly

Annual Cash Flows

(In USD)

Breakdown	2022	2021	2020	2019	2018	2017
Operating Cash Flow	-77.17 Thousand	-	-	-	-	-31.75 Thousand
Net Income	-78.98 Thousand	-	-	-	-	-31.75 Thousand
Depreciation & Amortization	-	-	-	-	-	-
Deferred income taxes	-	-	-	-	-	-
Stock-based compensation	-	-	-	-	-	-
Change in working capital	1816.00	-	-	-	-	-
Other non-cash items	-3.00	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-	-
Investments in PPE	-	-	-	-	-	-
Acquisitions	-	-	-	-	-	-
Investment purchases	-	-	-	-	-	-
Sales/Maturities of investments	-	-	-	-	-	-
Other Investing Activities	-	-	-	-	-	-
Financing Cash Flow	95.46 Thousand	-	-	-	-	56.53 Thousand
Debt repayment	-	-	-	-	-	-
Dividends payments	-	-	-	-	-	-
Common Stock Repurchased	-	-	-	-	-	-
Common Stock Issuance	95.46 Thousand	-	-	-	-	-
Other Financing Activities	-	-	-	-	-	56.53 Thousand
Accounts receivables	-	-	-	-	-	-
Accounts payables	-	-	-	-	-	-
Inventory	-	-	-	-	-	-
Other working capital	1816.00	-	-	-	-	-
Cash at beginning of period	-	-	-	-	-	-1.00
Cash at end of period	18.29 Thousand	-	-	-	-	24.77 Thousand
Capital Expenditure	-	-	-	-	-	-
Effect of forex changes on cash	-	-	-	-	-	-
Net cash flow / Change in cash	18.29 Thousand	-	-	-	-	24.77 Thousand
Free Cash Flow	-77.17 Thousand	-	-	-	-	-31.75 Thousand

Breakdown	2023 Q3	2023 Q2	2023 Q1	2022 FY	2022 Q4	2022 Q3
Operating Cash Flow	-	-	-	-	-	-
Net Income	-8746.00	-3746.00	-19.74 Thousand	-78.98 Thousand	-78.98 Thousand	-
Depreciation & Amortization	-	-	-	-	-	-
Deferred income taxes	-	-	-	-	-	-
Stock-based compensation	-	-	-	-	-	-
Change in working capital	-	-	-	1816.00	-	-
Other non-cash items	-	-	-	-3.00	1813.00	-
Investing Cash Flow	-	-	-	-	-	-
Investments in PPE	-	-	-	-	-	-
Acquisitions	-	-	-	-	-	-
Investment purchases	-	-	-	-	-	-
Sales/Maturities of investments	-	-	-	-	-	-
Other Investing Activities	-	-	-	-	-	-
Financing Cash Flow	5000.00	-	7000.00	95.46 Thousand	95.46 Thousand	-
Debt repayment	-	-	-	-	-	-
Dividends payments	-	-	-	-	-	-
Common Stock Repurchased	-	-	-	-	-	-
Common Stock Issuance	5000.00	-	7000.00	95.46 Thousand	95.46 Thousand	-
Other Financing Activities	-	-	-	-	-	-
Accounts receivables	-	-	-	-	-	-
Accounts payables	-	-	-	-	-	-
Inventory	-	-	-	-	-	-
Other working capital	-	-	-	1816.00	-	-
Cash at beginning of period	1804.00	5550.00	18.29 Thousand	-	-	-
Cash at end of period	1804.00	1804.00	5550.00	18.29 Thousand	18.29 Thousand	-
Capital Expenditure	-	-	-	-	-	-
Effect of forex changes on cash	-	-	-	-	-	-
Net cash flow / Change in cash	-	-3746.00	-12.74 Thousand	18.29 Thousand	18.29 Thousand	-
Free Cash Flow	-8746.00	-3746.00	-19.74 Thousand	-77.17 Thousand	-77.17 Thousand	-